{
    "Trade/Device Name(s)": [
        "Elecsys BRAHMS PCT",
        "Elecsys BRAHMS PCT CalCheck 5"
    ],
    "Submitter Information": "Roche Diagnostics",
    "510(k) Number": "K160729",
    "Predicate Device Reference 510(k) Number(s)": [
        "DEN150009",
        "K152526",
        "K150955"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "PMT",
        "JJX",
        "JIT",
        "JJY"
    ],
    "Summary Letter Date": "March 15, 2016",
    "Summary Letter Received Date": "March 16, 2016",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.3215",
        "862.1150",
        "862.1660"
    ],
    "Regulation Name(s)": [
        "Device to detect and measure non-microbial analyte(s) in human clinical specimens to aid in assessment of patients with suspected sepsis",
        "Multi-Analyte Control, All Kinds (Assayed)",
        "Single (specified) analyte Controls (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "immunology"
    ],
    "Analyte(s)": [
        "Procalcitonin (PCT)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma (K2 EDTA, K3 EDTA, Li-Heparin)"
    ],
    "Specimen Container(s)": [
        "Serum Separator Tubes (SST)",
        "Plasma Separation Tubes (PST)",
        "Primary tubes with appropriate anticoagulant"
    ],
    "Instrument(s)/Platform(s)": [
        "Elecsys immunoassay analyzers",
        "cobas e 411 analyzer",
        "cobas e 601 analyzer",
        "cobas e 602 analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemiluminescence immunoassay (ECLIA)"
    ],
    "Methodologies": [
        "Two-step sandwich immunoassay",
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Control",
        "Reference Material",
        "Standard",
        "System",
        "Platform",
        "Analyzer",
        "Quality control material"
    ],
    "Document Summary": "FDA 510(k) summary for Elecsys BRAHMS PCT immunoassay and CalCheck 5 for quantitative measurement of procalcitonin (PCT) in human serum and plasma for mortality risk assessment in severe sepsis or septic shock",
    "Indications for Use Summary": "Intended for in vitro quantitative determination of procalcitonin (PCT) in human serum and plasma as an aid in assessing cumulative 28-day risk of all-cause mortality in patients diagnosed with severe sepsis or septic shock; CalCheck 5 is used for calibration verification and assay range verification on Elecsys and cobas e analyzers.",
    "fda_folder": "Microbiology"
}